Managing cancer pain in the elderly

Cancer Pain: Assessment and Management, Second Edition

Volumn , Issue , 2009, Pages 444-454

  Delgado Guay, Marvin Omar ^a   Wollner, David ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Metropolitan Jewish Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857355429     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511642357.025     Document Type: Chapter

References (73)

1. Delgado-Guay MO, Bruera E. Management of pain in the older person with cancer. Part 1. Oncology 22:56-61, 2008.
2. Yennurajalingam S, Braiteh F, Bruera E. Pain and terminal delirium research in the elderly. Clin Geriatr Med 21:93-119, 2005.
3. Basso U, Monfardinin S. Multidimensional geriatric evaluation in elderly cancer patients: a practical approach. Eur J Cancer Care 13:424-33, 2004.
4. Mercadante S, Arcuri E. Pharmacological management of cancer pain in the elderly. Drugs Aging 24:761-76, 2007.
5. Dalal S, Del Fabbro E, Bruera E. Symptom control in palliative care - part 1: oncology as a paradigmatic example. J Palliat Med 9:391-408, 2006.
6. Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 46:417-43, 2007.
7. World Health Organization (WHO). Cancer pain relief. Geneva: WHO, 1986.
8. Goodlin S, Winzeleberg GS, Teno JM, et al. Death in the hospital. Arch Intern Med 158:1570-2, 1998.
9. Goldstein N, Morrison S. Treatment of pain in older patients. Crit Rev Oncol Hematol 54:157-64, 2005.
10. Cohen-Mansfield J. The adequacy of minimum data set assessment of pain in cognitively impaired nursing home residents. J Pain Symptom Manage 27:343-51, 2004.
11. Cleeland CS, Gonin R, Hartfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Eng J Med 330:592-6, 1994.
12. Bruera E. Research into symptoms other than pain. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford textbook of palliative medicine, 2nd ed. New York: Oxford University Press, 1998, pp 179-85.
13. Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893-903, 2000.
14. Edgards R, Fillingim R, Ness T. Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 101:155-65, 2003.
15. Gibson SJ, Helme RD. Age-related differences in pain perception and reports. Clin Geriatr Med 17:334-51, 2001.
16. Balducci L. Management of cancer pain in geriatric patients. J Support Oncol 1:175-91, 2003.
17. Davis MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging 20:23-57, 2003.
18. Clinch D, Banjeree AK, Ostik G. Absence of abdominal pain in the elderly patients with peptic ulcer. Age Ageing 13:120-6, 1984.
19. Wroblewski M, Mikulowski P. Peritonitis in geriatric inpatients. Age Ageing 20:90-102, 1992.
20. Landi F, Onder G, Cesari M, et al. Pain occurs daily, remains untreated among elderly patients in community settings. Arch Intern Med 161:2721-4, 2001.
21. Curless R, French JM, Williams GV, et al. Colorectal cancer: do elderly patients present differently? Age Ageing 23:102-8, 1994.
22. Vigano A, Bruera E, Suarez-Almazor ME. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83:1244-50, 1998.
23. Fuse PG. Opioid analgesic drugs in older people. Clin Geriatr Med 17:479-85, 2001.
24. Repetto L, Balducci L. A case for geriatric oncology. Lancet Oncol 3:289-97, 2003.
25. Hurria A, Lachs M, Cohen H, et al. Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol 59:211-17, 2006.
26. Coates A, Gebski V, Signorini D, et al. Prognostic values of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10:1833-8, 1992.
27. Miller F. Predicting survival in the advanced cancer patient. Henry Ford Hosp Med 391:81-4, 1991.
28. Schag C, Heinrich R, Ganz P. Karnofsky performance status revisited: reliability validity and guidelines. J Clin Oncol 2:187-93, 1984.
29. Yates J, Chalmer B, McKegney F. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220-4, 1980.
30. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function. JAMA 185:914-19, 1963.
31. Lawton MP, Brody EM. Assessment of older people: self- maintaining and instrumental activities of daily living. Gerontologist 9:179-86, 1969.
32. Reuben DB, Siu A. An objective measure of physical function of elderly out-patients. The physical performance test. J Am Geriatr Soc 38:1105-12, 1990.
33. Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373-83, 1987.
34. Miller M, Paradis C, Houck P, et al. Rating chronic medical illness burden in gero-psychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41:237-48, 1992.
35. Hickie C, Snowdon J. Depression scales for the elderly: GDS. Clin Gerontol 6:51-3, 1987.
36. Folstein M, Folstein S, McMugh P. Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psych Res 12:219-26, 1975.
37. Chang V, Hwang S, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 88:2164-71, 2000.
38. Chochinov H, Tataryn D, Clinch J, Dudgeon D. Will to live in the terminally ill. Lancet 354:816-19, 1999.
39. Philip J, Smith W, Craft P, Lickiss N. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 6:539-41, 1998.
40. Walke L, Gallo W, Tinetti M, Fried T. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 164:2321-4, 2004.
41. Vignaroli E, Pace E, Willey J, et al. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med 9:296-303, 2006.
42. Bruera E, Moyano J, Seifert L, et al. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 10:599-603, 1995.
43. Bruera E, Watanabe S. New developments in the assessment of pain in cancer patients. Support Care Cancer 2:312-18, 1994.
44. Lawlor P, Fainsinger R, Bruera E. Delirium at the end of life. Critical issues in clinical practice and research. JAMA 284:2427-9, 2000.
45. Lawlor P, Gagnon B, Mancini I, et al. Occurrence, causes, and outcome of delirium in advanced cancer patients: a prospective study. Arch Intern Med 160:786-94, 2000.
46. Lawlor P, Nekolaichuk C, Gagnon B, et al. Clinical utility, factor analysis, and further validation of the Memorial Delirium Assessment Scale in patients with advanced cancer. Cancer 88:2859-67, 2000.
47. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med 18:184-94, 2004.
48. Rooij SE, Schuurmans MJ, van dal Mast RC, Levi M. Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. Int J Geriatr Psychiatry 20:609-15, 2005.
49. Inouye S, van Dyck C, Alessi C, et al. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med 113:941-8, 1990.
50. Herr KA, Garand L. Assessment and measurement of pain in older adults. Clin Geriatr Med 17:457-78, 2001.
51. Pautex S, Michon A, Guedira M, et al. Pain in severe dementia: self-assessment or observational scales? J Am Geriatr Soc 56:1040-5, 2006.
52. Zech DFJ, Grond S, Lynch J, et al. Validation of the World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63:65-76, 1995.
53. Lipman AG, Gautier GM. Pharmacology of opioid drugs: basic principles. In: Portenoy RK, Bruera E, eds. Topics in palliative care, vol 1. New York: Oxford University Press, 1997, pp 13761.
54. Pasternak GW. The pharmacology of mu analgesics: from patients to genes. Neuroscientist 7:220-31, 2001.
55. Walsh D. Advances in opioid therapy and formulations. Support Care Cancer 13:138-44, 2005.
56. Bruera E, Rico MA, Bertolino M, et al. A prospective open study of oral methadone in the treatment of cancer pain. In: Devor M, Rowbotham MC, Weisenfield-Hallin Z, eds. Proceedings of the Ninth World Congress of Pain. Seattle: IASP Press, 2000, pp 957-63.
57. Ripamonti C, Bianchi M. The use of methadone for cancer pain. Hematol Oncol Clin North Am 2002, 16:543-4.
58. Murtagh F, Chai MO, Donohoe P, et al. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother 21:5-16, 2007.
59. Kreek MJ, Schecter AJ, Gutjahr CL, Hecht M. Methadone use in patients with chronic renal disease. Drug Alcohol Depend 5:197-205, 1980.
60. Murray A, Hagen N. Hydromorphone. J Pain Symptom Manage 29: S57-66, 2005.
61. Zheng M, McErlane KM, Ong MC. Hydromorphone metabolites: isolation and identification from pooled urine samples of cancer patient. Xenobiotica 32:427-39, 2002.
62. Boger RH. Renal impairment: a challenge for opioid treatment? The role of buprenorphine. Palliat Med 20:s17-23, 2006.
63. Guay DR. Use of oral oxymorphone in the elderly. Consult Pharm 22:417-430, 2007.
64. Chamberlin KW, Cottle M, Neville R, Tan J. Oral oxymorphone for pain management. Ann Pharmacother 41:1144-52, 2007.
65. De Leon-Casasola OA. Current developments in opioid therapy for management of cancer pain. Clin J Pain 24(Suppl 10): S3-7, 2008.
66. Pickering G, Capriz-Ribiere F. Neuropathic pain in the elderly. Psychol Neuropsychiatr Vieil 6:107-14, 2008.
67. McGeeney BE. Adjuvant agents in cancer pain. Clin J Pain 24: S14-20, 2008.
68. Donnelly S, Davis MP, Walsh D, et al. Morphine in cancer pain management: a practical guide. Support Care Cancer 10:13-35, 2002.
69. Portenoy RK, Thomas J, Moehl Boatwright ML, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 35:458-68, 2008.
70. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358:2332-43, 2008.
71. Estfan B, Mahmoud F, Shaheen P, et al. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med 21:81-6, 2007.
72. Clemens K, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage 33:473-81, 2007.
73. Sinclair S, Raffin S, Pereira J, Guebert N. Collective soul: the spirituality of an interdisciplinary palliative care team. Palliat Support Care 4:13-24, 2006.